跳至主要内容
临床试验/CTRI/2023/08/056474
CTRI/2023/08/056474尚未招募Unknown

Effectiveness and Tolerability of Cephalexin and Clavulanic Acid Fixed Dose Combination,Amoxicillin and Clavulanic Acid Fixed Dose Combination, and Azithromycin in Patients withPHARYngitis in India: A Real-World RetroSPective Study from ElectrOnic Medical Records(PHARYSPOR) - NI

Sun Pharmaceutical Industries Limited (SPIL)0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Adult patients aged more than or equal to 18 years of either gender
  • 2. Patients with signs and symptoms of pharyngitis suggestive of bacteriological
  • etiology, alone or in combination (fever, sore throat, throat pain/difficulty in
  • swallowing, inflammation of tonsils) at the initiation of treatment
  • 3. Patients prescribed with oral cephalexin and clavulanic acid combination or
  • other commonly prescribed antibiotics (Amoxicillin + clavulanic acid or
  • Azithromycin) for the management of pharyngitis

排除标准

  • 1. Patients with incomplete medical records with respect to the required study
  • 2. Patients requiring hospitalization or parenteral antibiotic treatment
  • 3. Patients with history of allergy or contraindications to study medications

研究者

发起方
Sun Pharmaceutical Industries Limited (SPIL)

相似试验

A Real World Evidence study to understand the... | 临床试验